Lauren Krupp, MD

More effective diagnostic tools have lead to a greater understanding of pediatric multiple sclerosis (MS), a disease that was, until now, believed to primarily affect adults. Multiple Sclerosis is now known to affect eight to ten thousand children under the age of eighteen, while still another ten to fifteen thousand suffer from what could be symptoms of MS. To help focus efforts to combat this disease, the National MS Society has established a network of Pediatric MS Centers of Excellence throughout the United States. Six such centers have been designated to date.
One of these newly-established centers is here at Stony Brook headed by Dr. Lauren Krupp. Dr. Krupp, professor of Neurology and Co-Director of the MS Comprehensive Care Center at Stony Brook, will serve as project director and will be responsible for successfully leading the center to meet the goals "fighting to end the devastating effects of MS". She will also chair the Steering Committee that will ensure that all six centers work together by collecting standardized data and sharing resources to treat as many children as possible while setting a comprehensive care plan for pediatric MS patients now and in the future. This includes accurate diagnosis, treatment, rehabilitation, psycho-social issues as well as educational components. Additional information about the National Pediatric MS Center at Stony Brook is available at pediatricmscenter.org

• Subcutaneous interferon beta-1a in pediatric patients with multiple sclerosis: Regional differences in clinical features, disease management, and treatment outcomes in an international retrospective study.
  
  Krupp LB | Pohl D | Ghezzi A | Boyko A | Tenembaum S | Chen L | Aycardi E | Banwell B
  Journal of the neurological sciences
  2016 Apr 15
  
  
• Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.
  
  Charvet L | Cersosimo B | Schwarz C | Belman A | Krupp LB
  Journal of child neurology
  2016 Mar 9
  
  
• A case-control study of dietary salt intake in pediatric-onset multiple sclerosis.
  
  McDonald J | Graves J | Waldman A | Lotze T | Schreiner T | Belman A | Greenberg B | Weinstock-Guttman B | Aaen G | Tillema JM | Hart J | Lulu S | Ness J | Harris Y | Rubin J | Candee M | Krupp LB | Gorman M | Benson L | Rodriguez M | Chitnis T | Mar S | Barcellos LF | Laraia B | Rose J | Roalstad S | Simmons T | Casper TC | Waubant E
  Multiple sclerosis and related disorders
  2016 Mar
  
  
• Genetic predictors of relapse rate in pediatric MS.
  
  Graves JS | Barcellos LF | Shao X | Noble J | Mowry EM | Quach H | Belman A | Casper TC | Krupp LB | Waubant E
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2016 Jan 14
  
  
• Clinical features of neuromyelitis optica in children: US Network of Pediatric MS Centers report.
  
  Chitnis T | Ness J | Krupp L | Waubant E | Hunt T | Olsen CS | Rodriguez M | Lotze T | Gorman M | Benson L | Belman A | Weinstock-Guttman B | Aaen G | Graves J | Patterson M | Rose JW | Casper TC
  Neurology
  2016 Jan 19
  
  
• The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.
  
  Casper TC | Rose JW | Roalstad S | Waubant E | Aaen G | Belman A | Chitnis T | Gorman M | Krupp L | Lotze TE | Ness J | Patterson M | Rodriguez M | Weinstock-Guttman B | Browning B | Graves J | Tillema JM | Benson L | Harris Y
  Journal of child neurology
  2015 Sep
  
  
• Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
  
  Weinfurtner K | Graves J | Ness J | Krupp L | Milazzo M | Waubant E
  Journal of child neurology
  2015 Sep
  
  
• Neuropsychological correlates of multiple sclerosis across the lifespan.
  
  Nunan-Saah J | Paulraj SR | Waubant E | Krupp LB | Gomez RG
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2015 Oct
  
  
• The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS).
  
  Charvet LE | Beekman R | Amadiume N | Belman AL | Krupp LB
  Journal of the neurological sciences
  2014 Jun 15
  
  
• Psychiatric diagnoses and cognitive impairment in pediatric multiple sclerosis.
  
  Weisbrot D | Charvet L | Serafin D | Milazzo M | Preston T | Cleary R | Moadel T | Seibert M | Belman A | Krupp L
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2014 Apr
  
  
• Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
  
  Lublin FD | Bowen JD | Huddlestone J | Kremenchutzky M | Carpenter A | Corboy JR | Freedman MS | Krupp L | Paulo C | Hariri RJ | Fischkoff SA
  Multiple sclerosis and related disorders
  2014 Nov
  
  
• Protective environmental factors for neuromyelitis optica.
  
  Graves J | Grandhe S | Weinfurtner K | Krupp L | Belman A | Chitnis T | Ness J | Weinstock-Guttman B | Gorman M | Patterson M | Rodriguez M | Lotze T | Aaen G | Mowry EM | Rose JW | Simmons T | Casper TC | James J | Waubant E
  Neurology
  2014 Nov 18
  
  
• Longitudinal evaluation of cognitive functioning in pediatric multiple sclerosis: report from the US Pediatric Multiple Sclerosis Network.
  
  Charvet LE | O'Donnell EH | Belman AL | Chitnis T | Ness JM | Parrish J | Patterson M | Rodriguez M | Waubant E | Weinstock-Guttman B | Krupp LB
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2014 Oct
  
  
• Social cognition in pediatric-onset multiple sclerosis (MS).
  
  Charvet LE | Cleary RE | Vazquez K | Belman AL | Krupp LB
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2014 Oct
  
  
• International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions.
  
  Krupp LB | Tardieu M | Amato MP | Banwell B | Chitnis T | Dale RC | Ghezzi A | Hintzen R | Kornberg A | Pohl D | Rostasy K | Tenembaum S | Wassmer E
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2013 Sep
  
  
• Subcutaneous interferon Beta-1a in pediatric multiple sclerosis: a retrospective study.
  
  Tenembaum SN | Banwell B | Pohl D | Krupp LB | Boyko A | Meinel M | Lehr L | Rocak S | Cantogno EV | Moraga MS | Ghezzi A
  Journal of child neurology
  2013 Jul
  
  
• Copy number variation in pediatric multiple sclerosis.
  
  McElroy JP | Krupp LB | Johnson BA | McCauley JL | Qi Z | Caillier SJ | Gourraud PA | Yu J | Nathanson L | Belman AL | Hauser SL | Waubant E | Hedges DJ | Oksenberg JR
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2013 Jul
  
  
• Antibody response to common viruses and human leukocyte antigen-DRB1 in pediatric multiple sclerosis.
  
  Waubant E | Mowry EM | Krupp L | Chitnis T | Yeh EA | Kuntz N | Ness J | Belman A | Milazzo M | Gorman M | Weinstock-Guttman B | Rodriguez M | James JA
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2013 Jun
  
  
• Treatment of cognitive impairment in multiple sclerosis: position paper.
  
  Amato MP | Langdon D | Montalban X | Benedict RH | DeLuca J | Krupp LB | Thompson AJ | Comi G
  Journal of neurology
  2013 Jun
  
  
• Parainfectious meningo-encephalo-radiculo-myelitis (cat scratch disease, Lyme borreliosis, brucellosis, botulism, legionellosis, pertussis, mycoplasma).
  
  Greenblatt D | Krupp LB | Belman AL
  Handbook of clinical neurology
  2013
  
  
• International Pediatric MS Study Group Clinical Trials Summit: meeting report.
  
  Chitnis T | Tardieu M | Amato MP | Banwell B | Bar-Or A | Ghezzi A | Kornberg A | Krupp LB | Pohl D | Rostasy K | Tenembaum S | Waubant E | Wassmer E
  Neurology
  2013 Mar 19
  
  
• Metabolomic approach to human brain spectroscopy identifies associations between clinical features and the frontal lobe metabolome in multiple sclerosis.
  
  Vingara LK | Yu HJ | Wagshul ME | Serafin D | Christodoulou C | Pelczer I | Krupp LB | Maletic-Savatic M
  NeuroImage
  2013 Nov 15
  
  
• Quantitative MRI analysis in children with multiple sclerosis: a multicenter feasibility pilot study.
  
  Chitnis T | Guttmann CR | Zaitsev A | Musallam A | Weinstock-Guttman B | Yeh A | Rodriguez M | Ness J | Gorman MP | Healy BC | Kuntz N | Chabas D | Strober JB | Waubant E | Krupp L | Pelletier D | Erickson B | Bergsland N | Zivadinov R
  BMC neurology
  2013
  
  
• Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy.
  
  Kluger BM | Krupp LB | Enoka RM
  Neurology
  2013 Jan 22
  
  
• Cognitive impairment occurs in children and adolescents with multiple sclerosis: results from a United States network.
  
  Julian L | Serafin D | Charvet L | Ackerson J | Benedict R | Braaten E | Brown T | O'Donnell E | Parrish J | Preston T | Zaccariello M | Belman A | Chitnis T | Gorman M | Ness J | Patterson M | Rodriguez M | Waubant E | Weinstock-Guttman B | Yeh A | Krupp LB
  Journal of child neurology
  2013 Jan
  
  
• Pediatric multiple sclerosis: what we know and where are we headed?
  
  MacAllister WS | Christodoulou C | Milazzo M | Preston TE | Serafin D | Krupp LB | Harder L
  Child neuropsychology : a journal on normal and abnormal development in childhood and adolescence
  2013
  
  
• Regression-based norms improve the sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
  
  Smerbeck AM | Parrish J | Yeh EA | Weinstock-Guttman B | Hoogs M | Serafin D | Krupp L | Benedict RH
  The Clinical neuropsychologist
  2012
  
  
• Brief International Cognitive Assessment for MS (BICAMS): international standards for validation.
  
  Benedict RH | Amato MP | Boringa J | Brochet B | Foley F | Fredrikson S | Hamalainen P | Hartung H | Krupp L | Penner I | Reder AT | Langdon D
  BMC neurology
  2012
  
  
• Recommendations for a Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
  
  Langdon DW | Amato MP | Boringa J | Brochet B | Foley F | Fredrikson S | Hamalainen P | Hartung HP | Krupp L | Penner IK | Reder AT | Benedict RH
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2012 Jun
  
  
• Unemployment in multiple sclerosis: the contribution of personality and disease.
  
  Strober LB | Christodoulou C | Benedict RH | Westervelt HJ | Melville P | Scherl WF | Weinstock-Guttman B | Rizvi S | Goodman AD | Krupp LB
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2012 May
  
  
• Multiple white matter tract abnormalities underlie cognitive impairment in RRMS.
  
  Yu HJ | Christodoulou C | Bhise V | Greenblatt D | Patel Y | Serafin D | Maletic-Savatic M | Krupp LB | Wagshul ME
  NeuroImage
  2012 Feb 15
  
  
• Consensus statement: evaluation of new and existing therapeutics for pediatric multiple sclerosis.
  
  Chitnis T | Tenembaum S | Banwell B | Krupp L | Pohl D | Rostasy K | Yeh EA | Bykova O | Wassmer E | Tardieu M | Kornberg A | Ghezzi A
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2012 Jan
  
  
• Common viruses associated with lower pediatric multiple sclerosis risk.
  
  Waubant E | Mowry EM | Krupp L | Chitnis T | Yeh EA | Kuntz N | Ness J | Chabas D | Strober J | McDonald J | Belman A | Milazzo M | Gorman M | Weinstock-Guttman B | Rodriguez M | Oksenberg JR | James JA
  Neurology
  2011 Jun 7
  
  
• Vitamin D status and antibody levels to common viruses in pediatric-onset multiple sclerosis.
  
  Mowry EM | James JA | Krupp LB | Waubant E
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2011 Jun
  
  
• Pediatric multiple sclerosis.
  
  Chitnis T | Krupp L | Yeh A | Rubin J | Kuntz N | Strober JB | Chabas D | Weinstock-Guttmann B | Ness J | Rodriguez M | Waubant E
  Neurologic clinics
  2011 May
  
  
• Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis.
  
  Krupp LB | Christodoulou C | Melville P | Scherl WF | Pai LY | Muenz LR | He D | Benedict RH | Goodman A | Rizvi S | Schwid SR | Weinstock-Guttman B | Westervelt HJ | Wishart H
  Neurology
  2011 Apr 26
  
  
• Visual-cognitive processing deficits in pediatric multiple sclerosis.
  
  Smerbeck AM | Parrish J | Serafin D | Yeh EA | Weinstock-Guttman B | Hoogs M | Krupp LB | Benedict RH
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2011 Apr
  
  
• Multiple sclerosis therapies in pediatric patients with refractory multiple sclerosis.
  
  Yeh EA | Waubant E | Krupp LB | Ness J | Chitnis T | Kuntz N | Ramanathan M | Belman A | Chabas D | Gorman MP | Rodriguez M | Rinker JR 2nd | Weinstock-Guttman B
  Archives of neurology
  2011 Apr
  
  
• Regression-based pediatric norms for the brief visuospatial memory test: revised and the symbol digit modalities test.
  
  Smerbeck AM | Parrish J | Yeh EA | Hoogs M | Krupp LB | Weinstock-Guttman B | Benedict RH
  The Clinical neuropsychologist
  2011 Apr
  
  
• Multiple sclerosis-associated fatigue.
  
  Krupp LB | Serafin DJ | Christodoulou C
  Expert review of neurotherapeutics
  2010 Sep
  
  
• Down a slippery slope: cognitive changes in pediatric MS.
  
  Krupp LB | Benedict RH
  Neurology
  2010 Sep 28
  
  
• Rapid disease course in African Americans with multiple sclerosis.
  
  Kister I | Chamot E | Bacon JH | Niewczyk PM | De Guzman RA | Apatoff B | Coyle P | Goodman AD | Gottesman M | Granger C | Jubelt B | Krupp L | Lenihan M | Lublin F | Mihai C | Miller A | Munschauer FE 3rd | Perel AB | Teter BE | Weinstock-Guttman B | Zivadinov R | Herbert J
  Neurology
  2010 Jul 20
  
  
• Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
  
  O'Connor KC | Lopez-Amaya C | Gagne D | Lovato L | Moore-Odom NH | Kennedy J | Krupp L | Tenembaum S | Ness J | Belman A | Boyko A | Bykova O | Mah JK | Stoian CA | Waubant E | Kremenchutzky M | Ruggieri M | Bardini MR | Rensel M | Hahn J | Weinstock-Guttman B | Yeh EA | Farrell K | Freedman MS | Iivanainen M | Bhan V | Dilenge M | Hancock MA | Gano D | Fattahie R | Kopel L | Fournier AE | Moscarello M | Banwell B | Bar-Or A
  Journal of neuroimmunology
  2010 Jun
  
  
• Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
  
  Mowry EM | Krupp LB | Milazzo M | Chabas D | Strober JB | Belman AL | McDonald JC | Oksenberg JR | Bacchetti P | Waubant E
  Annals of neurology
  2010 May
  
  
• Treatment of multiple sclerosis in children and adolescents.
  
  Kuntz NL | Chabas D | Weinstock-Guttman B | Chitnis T | Yeh EA | Krupp L | Ness J | Rodriguez M | Waubant E
  Expert opinion on pharmacotherapy
  2010 Mar
  
  
• Younger children with MS have a distinct CSF inflammatory profile at disease onset.
  
  Chabas D | Ness J | Belman A | Yeh EA | Kuntz N | Gorman MP | Strober JB | De Kouchkovsky I | McCulloch C | Chitnis T | Rodriguez M | Weinstock-Guttman B | Krupp LB | Waubant E
  Neurology
  2010 Feb 2
  
  
• Psychiatric comorbidity in pediatric patients with demyelinating disorders.
  
  Weisbrot DM | Ettinger AB | Gadow KD | Belman AL | MacAllister WS | Milazzo M | Reed ML | Serrano D | Krupp LB
  Journal of child neurology
  2010 Feb
  
  
• A phase 3 trial of extended release oral dalfampridine in multiple sclerosis.
  
  Goodman AD | Brown TR | Edwards KR | Krupp LB | Schapiro RT | Cohen R | Marinucci LN | Blight AR
  Annals of neurology
  2010 Oct
  
  
• Protein expression profiles in pediatric multiple sclerosis: potential biomarkers.
  
  Rithidech KN | Honikel L | Milazzo M | Madigan D | Troxell R | Krupp LB
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2009 Apr
  
  
• Longitudinal correlates of fatigue in multiple sclerosis.
  
  Patrick E | Christodoulou C | Krupp LB
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2009 Feb
  
  
• Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.
  
  Goodman AD | Brown TR | Krupp LB | Schapiro RT | Schwid SR | Cohen R | Marinucci LN | Blight AR
  Lancet
  2009 Feb 28
  
  
• Fatigue and quality of life in pediatric multiple sclerosis.
  
  MacAllister WS | Christodoulou C | Troxell R | Milazzo M | Block P | Preston TE | Bender HA | Belman A | Krupp LB
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2009 Dec
  
  
• Pediatric multiple sclerosis.
  
  Yeh EA | Chitnis T | Krupp L | Ness J | Chabas D | Kuntz N | Waubant E
  Nature reviews. Neurology
  2009 Nov
  
  
• Pediatric multiple sclerosis.
  
  Patel Y | Bhise V | Krupp L
  Annals of Indian Academy of Neurology
  2009 Oct
  
  
• Negative affect predicts subsequent cognitive change in multiple sclerosis.
  
  Christodoulou C | Melville P | Scherl WF | Macallister WS | Abensur RL | Troxell RM | Krupp LB
  Journal of the International Neuropsychological Society : JINS
  2009 Jan
  
  
• Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients.
  
  Jacob A | Weinshenker BG | Violich I | McLinskey N | Krupp L | Fox RJ | Wingerchuk DM | Boggild M | Constantinescu CS | Miller A | De Angelis T | Matiello M | Cree BA
  Archives of neurology
  2008 Nov
  
  
• Dose comparison trial of sustained-release fampridine in multiple sclerosis.
  
  Goodman AD | Brown TR | Cohen JA | Krupp LB | Schapiro R | Schwid SR | Cohen R | Marinucci LN | Blight AR
  Neurology
  2008 Oct 7
  
  
• Pilot study exploring quality of life and barriers to leisure-time physical activity in persons with moderate to severe multiple sclerosis.
  
  Vanner EA | Block P | Christodoulou CC | Horowitz BP | Krupp LB
  Disability and health journal
  2008 Jan
  
  
• Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
  
  Banwell B | Bar-Or A | Cheung R | Kennedy J | Krupp LB | Becker DJ | Dosch HM
  Annals of neurology
  2008 Jan
  
  
• Treatment of cognitive impairment in multiple sclerosis: is the use of acetylcholinesterase inhibitors a viable option?
  
  Christodoulou C | MacAllister WS | McLinskey NA | Krupp LB
  CNS drugs
  2008
  
  
• Metabolomics of neural progenitor cells: a novel approach to biomarker discovery.
  
  Maletic-Savatic M | Vingara LK | Manganas LN | Li Y | Zhang S | Sierra A | Hazel R | Smith D | Wagshul ME | Henn F | Krupp L | Enikolopov G | Benveniste H | Djuric PM | Pelczer I
  Cold Spring Harbor symposia on quantitative biology
  2008
  
  
• Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study.
  
  Banwell B | Krupp L | Kennedy J | Tellier R | Tenembaum S | Ness J | Belman A | Boiko A | Bykova O | Waubant E | Mah JK | Stoian C | Kremenchutzky M | Bardini MR | Ruggieri M | Rensel M | Hahn J | Weinstock-Guttman B | Yeh EA | Farrell K | Freedman M | Iivanainen M | Sevon M | Bhan V | Dilenge ME | Stephens D | Bar-Or A
  Lancet neurology
  2007 Sep
  
  
• Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.
  
  Halperin JJ | Shapiro ED | Logigian E | Belman AL | Dotevall L | Wormser GP | Krupp L | Gronseth G | Bever CT Jr
  Neurology
  2007 Jul 3
  
  
• Consensus definitions proposed for pediatric multiple sclerosis and related disorders.
  
  Krupp LB | Banwell B | Tenembaum S
  Neurology
  2007 Apr 17
  
  
• The psychosocial consequences of pediatric multiple sclerosis.
  
  MacAllister WS | Boyd JR | Holland NJ | Milazzo MC | Krupp LB
  Neurology
  2007 Apr 17
  
  
• Longitudinal neuropsychological assessment in pediatric multiple sclerosis.
  
  MacAllister WS | Christodoulou C | Milazzo M | Krupp LB
  Developmental neuropsychology
  2007
  
  
• Effects of donepezil on memory and cognition in multiple sclerosis.
  
  Christodoulou C | Melville P | Scherl WF | Macallister WS | Elkins LE | Krupp LB
  Journal of the neurological sciences
  2006 Jun 15
  
  
• Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.
  
  Banwell B | Reder AT | Krupp L | Tenembaum S | Eraksoy M | Alexey B | Pohl D | Freedman M | Schelensky L | Antonijevic I
  Neurology
  2006 Feb 28
  
  
• High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
  
  Gladstone DE | Zamkoff KW | Krupp L | Peyster R | Sibony P | Christodoulou C | Locher E | Coyle PK
  Archives of neurology
  2006 Oct
  
  
• Perceived cognitive dysfunction and observed neuropsychological performance: longitudinal relation in persons with multiple sclerosis.
  
  Christodoulou C | Melville P | Scherl WF | Morgan T | MacAllister WS | Canfora DM | Berry SA | Krupp LB
  Journal of the International Neuropsychological Society : JINS
  2005 Sep
  
  
• Multiple sclerosis-related fatigue.
  
  MacAllister WS | Krupp LB
  Physical medicine and rehabilitation clinics of North America
  2005 May
  
  
• Treatment of Pediatric Multiple Sclerosis.
  
  Krupp LB | Macallister WS
  Current treatment options in neurology
  2005 May
  
  
• Cognitive functioning in children and adolescents with multiple sclerosis.
  
  MacAllister WS | Belman AL | Milazzo M | Weisbrot DM | Christodoulou C | Scherl WF | Preston TE | Cianciulli C | Krupp LB
  Neurology
  2005 Apr 26
  
  
• Donepezil improved memory in multiple sclerosis in a randomized clinical trial.
  
  Krupp LB | Christodoulou C | Melville P | Scherl WF | MacAllister WS | Elkins LE
  Neurology
  2004 Nov 9
  
  
• Normative data for the selective reminding test: a random digit dialing sample.
  
  Scherl WF | Krupp LB | Christodoulou C | Morgan TM | Hyman L | Chandler B | Coyle PK | MacAllister WS
  Psychological reports
  2004 Oct
  
  
• Multiple sclerosis characteristics in African American patients in the New York State Multiple Sclerosis Consortium.
  
  Weinstock-Guttman B | Jacobs LD | Brownscheidle CM | Baier M | Rea DF | Apatoff BR | Blitz KM | Coyle PK | Frontera AT | Goodman AD | Gottesman MH | Herbert J | Holub R | Lava NS | Lenihan M | Lusins J | Mihai C | Miller AE | Perel AB | Snyder DH | Bakshi R | Granger CV | Greenberg SJ | Jubelt B | Krupp L | Munschauer FE | Rubin D | Schwid S | Smiroldo J
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2003 Jun
  
  
• Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients.
  
  Christodoulou C | Krupp LB | Liang Z | Huang W | Melville P | Roque C | Scherl WF | Morgan T | MacAllister WS | Li L | Tudorica LA | Li X | Roche P | Peyster R
  Neurology
  2003 Jun 10
  
  
• Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.
  
  Krupp LB | Hyman LG | Grimson R | Coyle PK | Melville P | Ahnn S | Dattwyler R | Chandler B
  Neurology
  2003 Jun 24
  
  
• Fatigue in multiple sclerosis: definition, pathophysiology and treatment.
  
  Krupp LB
  CNS drugs
  2003
  
  
• Metabolic differences between multiple sclerosis subtypes measured by quantitative MR spectroscopy.
  
  Pan JW | Coyle PK | Bashir K | Whitaker JN | Krupp LB | Hetherington HP
  Multiple sclerosis (Houndmills, Basingstoke, England)
  2002 May
  
  
• Symptomatic therapy for underrecognized manifestations of multiple sclerosis.
  
  Krupp LB | Rizvi SA
  Neurology
  2002 Apr 23
  
  
• Managing MS. While a cure is sought, people with MS can help themselves.
  
  Krupp L
  Health news (Waltham, Mass.)
  2002 Nov
  
  
• Fatigue in multiple sclerosis.
  
  Krupp LB | Christodoulou C
  Current neurology and neuroscience reports
  2001 May
  
  
• Cognitive dysfunction lateralizes with NAA in multiple sclerosis.
  
  Pan JW | Krupp LB | Elkins LE | Coyle PK
  Applied neuropsychology
  2001
  
  
• Are quantitative functional measures more sensitive to worsening MS than traditional measures?
  
  Schwid SR | Goodman AD | Apatoff BR | Coyle PK | Jacobs LD | Krupp LB | Miller AE | Wende KE | Brownscheidle CM | New York State Multiple Sclero
  Neurology
  2000 Dec 26
  
  
• Fatigue and declines in cognitive functioning in multiple sclerosis.
  
  Krupp LB | Elkins LE
  Neurology
  2000 Oct 10
  
  
• The measurement of fatigue and contributing neuropsychiatric factors.
  
  Elkins LE | Krupp LB | Scherl W
  Seminars in clinical neuropsychiatry
  2000 Jan
  
  
• Psychiatric disorders in patients with fibromyalgia. A multicenter investigation.
  
  Epstein SA | Kay G | Clauw D | Heaton R | Klein D | Krupp L | Kuck J | Leslie V | Masur D | Wagner M | Waid R | Zisook S
  Psychosomatics
  1999 Jan-Feb
  
  
• Does process-specific slowing account for cognitive deficits in Lyme disease?
  
  Pollina DA | Elkins LE | Squires NK | Scheffer SR | Krupp LB
  Applied neuropsychology
  1999
  
  
• Psychological states and neuropsychological performances in chronic Lyme disease.
  
  Elkins LE | Pollina DA | Scheffer SR | Krupp LB
  Applied neuropsychology
  1999
  
  
• A profile of multiple sclerosis: the New York State Multiple Sclerosis Consortium.
  
  Jacobs LD | Wende KE | Brownscheidle CM | Apatoff B | Coyle PK | Goodman A | Gottesman MH | Granger CV | Greenberg SJ | Herbert J | Krupp L | Lava NS | Mihai C | Miller AE | Perel A | Smith CR | Snyder DH
  Multiple sclerosis (Houndmills, Basingstoke, England)
  1999 Oct
  
  
• Cognitive processing speed in Lyme disease.
  
  Pollina DA | Sliwinski M | Squires NK | Krupp LB
  Neuropsychiatry, neuropsychology, and behavioral neurology
  1999 Jan
  
  
• Pain, fatigue, and sleep in eosinophilia-myalgia syndrome: relationship to neuropsychological performance.
  
  Pollina DA | Kaufman LD | Masur DM | Krupp LB
  The Journal of neuropsychiatry and clinical neurosciences
  1998 Summer
  
  
• Simultaneous expression of Borrelia OspA and OspC and IgM response in cerebrospinal fluid in early neurologic Lyme disease.
  
  Schutzer SE | Coyle PK | Krupp LB | Deng Z | Belman AL | Dattwyler R | Luft BJ
  The Journal of clinical investigation
  1997 Aug 15
  
  
• A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis.
  
  Miller AE | Morgante LA | Buchwald LY | Nutile SM | Coyle PK | Krupp LB | Doscher CA | Lublin FD | Knobler RL | Trantas F | Kelley L | Smith CR | La Rocca N | Lopez S
  Neurology
  1997 Feb
  
  
• Post-Lyme syndrome and chronic fatigue syndrome. Neuropsychiatric similarities and differences.
  
  Gaudino EA | Coyle PK | Krupp LB
  Archives of neurology
  1997 Nov
  
  
• Felbamate-induced headache.
  
  Ettinger AB | Jandorf L | Berdia A | Andriola MR | Krupp LB | Weisbrot DM
  Epilepsia
  1996 May
  
  
• The effects of amantadine and pemoline on cognitive functioning in multiple sclerosis.
  
  Geisler MW | Sliwinski M | Coyle PK | Masur DM | Doscher C | Krupp LB
  Archives of neurology
  1996 Feb
  
  
• Mechanisms and management of fatigue in progressive neurological disorders.